Holoclar

ex vivo expanded autologous human corneal epithelial cells containing stem cells · Holostem s.r.l.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Holoclar, covering 2025-07-08 to 2025-07-08. Get the full timeline:

Most recent: EMA Authorised: Holoclar (ex vivo expanded autologous human corneal epithelial cells containing stem cells) — Holostem s.r.l.